Melanoma trials in France

In France 61 Also abroad 578

19 of 61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Where
Toulouse
Age
18 years and over
People
100
Run by
Institut Claudius Regaud
See details and how to joinNCT05867004
No phaseTaking people
Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
Where
Besançon, Dijon, Lyon
Age
18 years and over
People
378
Run by
Centre Georges Francois Leclerc
See details and how to joinNCT07376512
No phaseTaking people
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Where
Besançon, Levallois-Perret, Marseille, Neuilly, Paris
Age
18 years and over
People
2,285 worldwide
Run by
Guardant Health, Inc.
See details and how to joinNCT05059444
Phase 3Enrolling by invitation
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Where
Lyon Cedex 04, Nice
Age
18 years and over
People
100 worldwide
Run by
Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00
No phaseTaking people
Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
Where
Montpellier
Age
18 years and over
People
160
Run by
University Hospital, Montpellier
See details and how to joinNCT06627595
No phaseTaking people
COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study
Where
Nantes
Age
18 years and over
People
40
Run by
Nantes University Hospital
See details and how to joinNCT07354152
No phaseTaking people
Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
Where
Angers, Besançon, Blois, Bordeaux, Brest, Dijon, Grenoble, La Rochelle, Le Mans, Lyon, Nantes, Paris, Rennes, Rouen, Saint-Herblain, Valence
Age
18 years and over
People
700
Run by
Nantes University Hospital
See details and how to joinNCT05856565
Phase 4Taking people
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Where
Lyon, Marseille, Villejuif
Age
18 years and over
People
50 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00
No phaseTaking people
Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
Where
Strasbourg
Age
18 years and over
People
221
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07302607
No phaseTaking people
Ovarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma
Where
Bordeaux, Marseille, Montpellier, Nantes, Nice, Nîmes, Paris, Toulouse, Villejuif
Age
18 years to 45 years
People
80
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT05429138
No phaseTaking people
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Where
Nantes
Age
18 years and over
People
16,000
Run by
Nantes University Hospital
See details and how to joinNCT03315468
No phaseNot yet taking people in France
Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL
Where
Nice
Age
18 years and over
People
70
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07046728
No phaseTaking people
APA (Adapted Physical Activity) for Patients With Advanced Melanoma
Where
Rouen
Age
18 years and over
People
50
Run by
University Hospital, Rouen
See details and how to joinNCT07031830
No phaseTaking people
Real-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma
Where
Boulogne-Billancourt
Age
18 years and over
People
66
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06774989
No phaseTaking people
Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma
Where
Nice
People
10
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06861023
No phaseTaking people
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
Where
Marseille
People
100 worldwide
Run by
Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT06605417
No phaseTaking people
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
Where
Amiens, Annecy, Besançon, Bobigny, Bordeaux, Boulogne-Billancourt, Brest, Caen, Créteil, Dijon, Grenoble, Lille, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Nîmes, Paris, Rennes, Toulouse
Age
18 years and over
People
6,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT02828202
No phaseTaking people
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
Where
Grenoble
Age
18 years and over
People
707
Run by
University Hospital, Grenoble
See details and how to joinNCT06154668
No phaseTaking people
Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma
Where
Pierre-Bénite
Age
18 years and over
People
1,000
Run by
Hospices Civils de Lyon
See details and how to joinNCT05527795